Artificial intelligence-driven peptide blocks gasdermin pyroptosis and alleviates inflammation
Precision Clinical Medicine · 30.01.2026 · 9 (1)
DOI: 10.1093/pcmedi/pbag004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Clinical Medicine, online erschienen am 10.03.2026. Verfasst von Mingsheng Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Second Ward of Urology, Qujing Central Hospital of Yunnan Province (Qujing Affiliated Hospital of Kunming Medical University), Qujing 655000, China. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, MOST, University of Chinese Academy of Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Second Ward of Urology, Qujing Central Hospital of Yunnan Province (Qujing Affiliated Hospital of Kunming Medical University), Qujing 655000, China.
- Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325001, China.
- Tianfu Jincheng Laboratory, Chengdu 610000, China.
- Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
ORCID-Profile: Min Wu
Förderung
- National Natural Science Foundation of China
- MOST
- University of Chinese Academy of Sciences
Zitieren
APA
Liu, M., Zhou, H., & Wu, M. (2026). Artificial intelligence-driven peptide blocks gasdermin pyroptosis and alleviates inflammation. Precision Clinical Medicine, 9(1). https://doi.org/10.1093/pcmedi/pbag004
Vancouver
Liu M, Zhou H, Wu M. Artificial intelligence-driven peptide blocks gasdermin pyroptosis and alleviates inflammation. Precision Clinical Medicine. 2026;9(1). doi:10.1093/pcmedi/pbag004
BibTeX
@article{Liu2026,
author = {Liu, Mingsheng and Zhou, Hongqing and Wu, Min},
title = {Artificial intelligence-driven peptide blocks gasdermin pyroptosis and alleviates inflammation},
journal = {Precision Clinical Medicine},
year = {2026},
volume = {9},
number = {1},
doi = {10.1093/pcmedi/pbag004}
}
EUVIMED